| Pharmaceutical active ingredients: |
| Galantamine Hydrobromide |
| Available forms, composition and doses of Reminyl ER: |
| Capsules, Extended Release; Oral; Galantamine Hydrobromide 16 mgCapsules, Extended Release; Oral; Galantamine Hydrobromide 24 mgCapsules, Extended Release; Oral; Galantamine Hydrobromide 8 mg |
| Reminyl ER medical category: |
| Human:Neurodegenerative disease drugsParasympathomemetic (cholinergic) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N06DA04 - Galantamine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Janssen |
| Related documents and information about Reminyl ER: |
| Reminyl prescribing information (PDF)Reminyl medication guide (PDF) |